psalexa

Molecular Cytogenetics Market by Offering (Consumables, Software & Services, Instruments), by Technology (Comparative Genomic Hybridization [Array Based, Standard], Fluorescence In-Situ Hybridization, Immunohistochemistry, Karyotyping [Spectral, Virtual]), by Application (Cancer, Genetic Disorders, Personalized Medicine), by End User (Clinical & Research Laboratories, Academic Research Institutes, Hospitals & Pathology Laboratories, Pharmaceutical & Biotechnology Companies), by Geography (U.S., Canada, Germany, U.K., Japan, China, Brazil, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2014–2023

  • Published: June 2018
  • Report Code: LS11474
  • Available Format: PDF
  • Pages: 203

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Offering

1.3.2 Market Segmentation by Technology

1.3.3 Market Segmentation by Application

1.3.4 Market Segmentation by End User

1.3.5 Market Segmentation by Geography

1.3.6 Analysis Period

1.3.7 Market Data Reporting Unit

1.3.7.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Offering

4.1.1.1 Consumables

4.1.1.2 Software and services

4.1.1.3 Instruments

4.1.2 By Technology

4.1.2.1 Comparative genomic hybridization (CGH)

4.1.2.1.1 Array-based CGH

4.1.2.1.2 Standard CGH

4.1.2.2 Fluorescence in situ hybridization (FISH)

4.1.2.3 Immunohistochemistry (IHC)

4.1.2.4 Karyotyping

4.1.2.4.1 Spectral karyotyping (SKY)

4.1.2.4.2 Virtual karyotyping

4.1.3 By Application

4.1.3.1 Cancer

4.1.3.2 Genetic disorders

4.1.3.3 Personalized medicine

4.1.3.4 Others

4.1.4 By End User

4.1.4.1 Clinical and research laboratories

4.1.4.2 Academic research institutes

4.1.4.3 Hospitals and pathology laboratories

4.1.4.4 Pharmaceutical and biotechnology companies

4.1.4.5 Others

4.2 Market Dynamics

4.2.1 Drivers

4.2.1.1 Rising pharmacogenomics for disease management and drug development

4.2.1.2 Rising prevalence of cancer

4.2.1.3 Advancements in molecular cytogenetic techniques

4.2.1.4 Growth in genetic-based prediction of chromosomal abnormalities

4.2.1.5 Increasing molecular cytogenetics application in crop improvement

4.2.1.6 Aging population and its vulnerability to chronic diseases

4.2.1.7 Impact analysis of drivers on market forecast

4.2.2 Restraints

4.2.2.1 High cost of cytogenetics instruments

4.2.2.2 Lack of skilled personnel

4.2.2.3 Lack of regulatory framework and insufficient reimbursements

4.2.2.4 Impact analysis of restraints on market forecast

4.3 Porter’s Five Forces Analysis

Chapter 5. Global Market Size and Forecast

5.1 By Offering

5.2 By Technology

5.2.1 CGH Molecular Cytogenetics Market by Type

5.2.2 Karyotyping Molecular Cytogenetics Market by Type

5.3 By Application

5.4 By End User

5.5 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Offering

6.2 By Technology

6.2.1 CGH Molecular Cytogenetics Market by Type

6.2.2 Karyotyping Molecular Cytogenetics Market by Type

6.3 By Application

6.4 By End User

6.5 By Country

6.5.1 U.S. Molecular Cytogenetics Market

6.5.1.1 By offering

6.5.1.2 By technology

6.5.1.2.1 CGH molecular cytogenetics market by type

6.5.1.2.2 Karyotyping molecular cytogenetics market by type

6.5.1.3 By application

6.5.1.4 By end user

6.5.2 Canada Molecular Cytogenetics Market

6.5.2.1 By offering

6.5.2.2 By technology

6.5.2.2.1 CGH molecular cytogenetics market by type

6.5.2.2.2 Karyotyping molecular cytogenetics market by type

6.5.2.3 By application

6.5.2.4 By end user

Chapter 7. Europe Market Size and Forecast

7.1 By Offering

7.2 By Technology

7.2.1 CGH Molecular Cytogenetics Market by Type

7.2.2 Karyotyping Molecular Cytogenetics Market by Type

7.3 By Application

7.4 By End User

7.5 By Country

7.5.1 Germany Molecular Cytogenetics Market

7.5.1.1 By offering

7.5.1.2 By technology

7.5.1.2.1 CGH molecular cytogenetics market by type

7.5.1.2.2 Karyotyping molecular cytogenetics market by type

7.5.1.3 By application

7.5.1.4 By end user

7.5.2 U.K. Molecular Cytogenetics Market

7.5.2.1 By offering

7.5.2.2 By technology

7.5.2.2.1 CGH molecular cytogenetics market by type

7.5.2.2.2 Karyotyping molecular cytogenetics market by type

7.5.2.3 By application

7.5.2.4 By end user

Chapter 8. APAC Market Size and Forecast

8.1 By Offering

8.2 By Technology

8.2.1 CGH Molecular Cytogenetics Market by Type

8.2.2 Karyotyping Molecular Cytogenetics Market by Type

8.3 By Application

8.4 By End User

8.5 By Country

8.5.1 Japan Molecular Cytogenetics Market

8.5.1.1 By offering

8.5.1.2 By technology

8.5.1.2.1 CGH molecular cytogenetics market by type

8.5.1.2.2 Karyotyping molecular cytogenetics market by type

8.5.1.3 By application

8.5.1.4 By end user

8.5.2 China Molecular Cytogenetics Market

8.5.2.1 By offering

8.5.2.2 By technology

8.5.2.2.1 CGH molecular cytogenetics market by type

8.5.2.2.2 Karyotyping molecular cytogenetics market by type

8.5.2.3 By application

8.5.2.4 By end user

Chapter 9. LATAM Market Size and Forecast

9.1 By Offering

9.2 By Technology

9.2.1 CGH Molecular Cytogenetics Market by Type

9.2.2 Karyotyping Molecular Cytogenetics Market by Type

9.3 By Application

9.4 By End User

9.5 By Country

9.5.1 Brazil Molecular Cytogenetics Market

9.5.1.1 By offering

9.5.1.2 By technology

9.5.1.2.1 CGH molecular cytogenetics market by type

9.5.1.2.2 Karyotyping molecular cytogenetics market by type

9.5.1.3 By application

9.5.1.4 By end user

Chapter 10. MEA Market Size and Forecast

10.1 By Offering

10.2 By Technology

10.2.1 CGH Molecular Cytogenetics Market by Type

10.2.2 Karyotyping Molecular Cytogenetics Market by Type

10.3 By Application

10.4 By End User

10.5 By Country

10.5.1 South Africa Molecular Cytogenetics Market

10.5.1.1 By offering

10.5.1.2 By technology

10.5.1.2.1 CGH molecular cytogenetics market by type

10.5.1.2.2 Karyotyping molecular cytogenetics market by type

10.5.1.3 By application

10.5.1.4 By end user

Chapter 11. Global Strategic Developments

11.1 Mergers and Acquisitions

11.2 Product Launches and Approvals

11.3 Partnerships

11.4 Other Developments

Chapter 12. Company Profiles

12.1 Abbott Laboratories

12.1.1 Business Overview

12.1.2 Product and Service Offerings

12.1.3 Key Financial Summary

12.2 Danaher Corporation

12.2.1 Business Overview

12.2.2 Product and Service Offerings

12.2.3 Key Financial Summary

12.3 Bio-Rad Laboratories Inc.

12.3.1 Business Overview

12.3.2 Product and Service Offerings

12.3.3 Key Financial Summary

12.4 F. Hoffmann La-Roche AG

12.4.1 Business Overview

12.4.2 Product and Service Offerings

12.4.3 Key Financial Summary

12.5 Agilent Technologies Inc.

12.5.1 Business Overview

12.5.2 Product and Service Offerings

12.5.3 Key Financial Summary

12.6 PerkinElmer Inc.

12.6.1 Business Overview

12.6.2 Product and Service Offerings

12.6.3 Key Financial Summary

12.7 Illumina Inc.

12.7.1 Business Overview

12.7.2 Product and Service Offerings

12.7.3 Key Financial Summary

12.8 Quest Diagnostics Inc.

12.8.1 Business Overview

12.8.2 Product and Service Offerings

12.8.3 Key Financial Summary

12.9 NeoGenomics Inc.

12.9.1 Business Overview

12.9.2 Product and Service Offerings

12.9.3 Key Financial Summary

Chapter 13. Appendix

13.1 Abbreviations

13.2 Sources and References

13.3 Related Reports

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 5 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 6 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 7 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 8 GLOBAL CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 9 GLOBAL CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 10 GLOBAL KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 11 GLOBAL KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 12 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 13 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 14 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 15 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 16 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY REGION, $M (2014–2017)

TABLE 17 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY REGION, $M (2018–2023)

TABLE 18 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 19 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 20 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 21 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 22 NORTH AMERICA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 23 NORTH AMERICA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 24 NORTH AMERICA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 25 NORTH AMERICA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 26 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 27 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 28 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 29 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 30 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014–2017)

TABLE 31 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2018–2023)

TABLE 32 U.S. MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 33 U.S. MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 34 U.S. MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 35 U.S. MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 36 U.S. CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 37 U.S. CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 38 U.S. KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 39 U.S. KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 40 U.S. MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 41 U.S. MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 42 U.S. MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 43 U.S. MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 44 CANADA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 45 CANADA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 46 CANADA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 47 CANADA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 48 CANADA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 49 CANADA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 50 CANADA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 51 CANADA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 52 CANADA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 53 CANADA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 54 CANADA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 55 CANADA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 56 EUROPE MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 57 EUROPE MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 58 EUROPE MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 59 EUROPE MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 60 EUROPE CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 61 EUROPE CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 62 EUROPE KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 63 EUROPE KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 64 EUROPE MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 65 EUROPE MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 66 EUROPE MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 67 EUROPE MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 68 EUROPE MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014–2017)

TABLE 69 EUROPE MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2018–2023)

TABLE 70 GERMANY MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 71 GERMANY MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 72 GERMANY MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 73 GERMANY MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 74 GERMANY CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 75 GERMANY CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 76 GERMANY KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 77 GERMANY KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 78 GERMANY MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 79 GERMANY MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 80 GERMANY MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 81 GERMANY MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 82 U.K. MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 83 U.K. MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 84 U.K. MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 85 U.K. MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 86 U.K. CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 87 U.K. CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 88 U.K. KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 89 U.K. KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 90 U.K. MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 91 U.K. MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 92 U.K. MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 93 U.K. MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 94 APAC MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 95 APAC MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 96 APAC MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 97 APAC MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 98 APAC CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 99 APAC CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 100 APAC KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 101 APAC KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 102 APAC MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 103 APAC MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 104 APAC MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 105 APAC MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 106 APAC MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014–2017)

TABLE 107 APAC MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2018–2023)

TABLE 108 JAPAN MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 109 JAPAN MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 110 JAPAN MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 111 JAPAN MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 112 JAPAN CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 113 JAPAN CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 114 JAPAN KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 115 JAPAN KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 116 JAPAN MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 117 JAPAN MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 118 JAPAN MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 119 JAPAN MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 120 CHINA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 121 CHINA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 122 CHINA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 123 CHINA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 124 CHINA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 125 CHINA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 126 CHINA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 127 CHINA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 128 CHINA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 129 CHINA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 130 CHINA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 131 CHINA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 132 LATAM MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 133 LATAM MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 134 LATAM MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 135 LATAM MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 136 LATAM CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 137 LATAM CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 138 LATAM KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 139 LATAM KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 140 LATAM MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 141 LATAM MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 142 LATAM MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 143 LATAM MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 144 LATAM MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014–2017)

TABLE 145 LATAM MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2018–2023)

TABLE 146 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 147 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 148 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 149 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 150 BRAZIL CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 151 BRAZIL CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 152 BRAZIL KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 153 BRAZIL KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 154 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 155 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 156 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 157 BRAZIL MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 158 MEA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 159 MEA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 160 MEA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 161 MEA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 162 MEA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 163 MEA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 164 MEA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 165 MEA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 166 MEA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 167 MEA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 168 MEA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 169 MEA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 170 MEA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014–2017)

TABLE 171 MEA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2018–2023)

TABLE 172 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2017)

TABLE 173 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2018–2023)

TABLE 174 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2017)

TABLE 175 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2018–2023)

TABLE 176 SOUTH AFRICA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 177 SOUTH AFRICA CGH MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 178 SOUTH AFRICA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2014–2017)

TABLE 179 SOUTH AFRICA KARYOTYPING MOLECULAR CYTOGENETICS MARKET, BY TYPE, $M (2018–2023)

TABLE 180 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2017)

TABLE 181 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2018–2023)

TABLE 182 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2017)

TABLE 183 SOUTH AFRICA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2018–2023)

TABLE 184 ABBOTT LABORATORIES – AT A GLANCE

TABLE 185 ABBOTT LABORATORIES – KEY FINANCIAL SUMMARY

TABLE 186 DANAHER CORPORATION – AT A GLANCE

TABLE 187 DANAHER CORPORATION – KEY FINANCIAL SUMMARY

TABLE 188 BIO-RAD LABORATORIES – AT A GLANCE

TABLE 189 BIO-RAD LABORATORIES, INC. – KEY FINANCIAL SUMMARY

TABLE 190 F. HOFFMANN LA-ROCHE AG – AT A GLANCE

TABLE 191 F. HOFFMANN LA-ROCHE AG – KEY FINANCIAL SUMMARY

TABLE 192 AGILENT TECHNOLOGIES INC. – AT A GLANCE

TABLE 193 AGILENT TECHNOLOGIES INC. – KEY FINANCIAL SUMMARY

TABLE 194 PERKINELMER INC. – AT A GLANCE

TABLE 195 PERKINELMER INC. – KEY FINANCIAL SUMMARY

TABLE 196 ILLUMINA INC. – AT A GLANCE

TABLE 197 ILLUMINA INC. – KEY FINANCIAL SUMMARY

TABLE 198 QUEST DIAGNOSTICS INC.– AT A GLANCE

TABLE 199 QUEST DIAGNOSTICS INC. – KEY FINANCIAL SUMMARY

TABLE 200 NEOGENOMICS INC.– AT A GLANCE

TABLE 201 NEOGENOMICS INC. – KEY FINANCIAL SUMMARY

LIST OF FIGURES

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL MOLECULAR CYTOGENETICS SUMMARY

FIG 9 PORTER’S FIVE FORCES ANALYSIS

FIG 10 SNAPSHOT OF GLOBAL MOLECULAR CYTOGENETICS MARKET (2017)

FIG 11 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2023)

FIG 12 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2023)

FIG 13 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2023)

FIG 14 GLOBAL MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2023)

FIG 15 WORLDWIDE MAJOR MARKETS FOR MOLECULAR CYTOGENETICS

FIG 16 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET SNAPSHOT

FIG 17 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2023)

FIG 18 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2023)

FIG 19 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2023)

FIG 20 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2023)

FIG 21 NORTH AMERICA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014–2023)

FIG 22 EUROPE MOLECULAR CYTOGENETICS MARKET SNAPSHOT

FIG 23 EUROPE MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2023)

FIG 24 EUROPE MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2023)

FIG 25 EUROPE MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2023)

FIG 26 EUROPE MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2023)

FIG 27 EUROPE MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014–2023)

FIG 28 APAC MOLECULAR CYTOGENETICS MARKET SNAPSHOT

FIG 29 APAC MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2023)

FIG 30 APAC MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2023)

FIG 31 APAC MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2023)

FIG 32 APAC MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2023)

FIG 33 APAC MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014–2023)

FIG 34 LATAM MOLECULAR CYTOGENETICS MARKET SNAPSHOT

FIG 35 LATAM MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2023)

FIG 36 LATAM MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2023)

FIG 37 LATAM MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2023)

FIG 38 LATAM MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2023)

FIG 39 LATAM MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014–2023)

FIG 40 MEA MOLECULAR CYTOGENETICS MARKET SNAPSHOT

FIG 41 MEA MOLECULAR CYTOGENETICS MARKET, BY OFFERING, $M (2014–2023)

FIG 42 MEA MOLECULAR CYTOGENETICS MARKET, BY TECHNOLOGY, $M (2014–2023)

FIG 43 MEA MOLECULAR CYTOGENETICS MARKET, BY APPLICATION, $M (2014–2023)

FIG 44 MEA MOLECULAR CYTOGENETICS MARKET, BY END USER, $M (2014–2023)

FIG 45 MEA MOLECULAR CYTOGENETICS MARKET, BY COUNTRY, $M (2014–2023)

FIG 46 ABBOTT LABORATORIES – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)

FIG 47 DANAHER CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)

FIG 48 BIO-RAD LABORATORIES REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2017)

FIG 49 F. HOFFMANN LA-ROCHE AG - REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2017)

FIG 50 AGILENT TECHNOLOGIES INC. – REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2017)

FIG 51 PERKINELMER INC. – REVENUE SPLIT BY GEOGRAPHY AND SEGMENT (2017)

FIG 52 ILLUMINA INC. – REVENUE SPLIT BY GEOGRAPHY (2017)

FIG 53 QUEST DIAGNOSTICS INC. - REVENUE SPLIT BY SEGMENT (2017)

FIG 54 NEOGENOMICS INC. – REVENUE SPLIT BY SEGMENT (2017)

Place An Order
USD 4900 USD 5900 USD 7500
Customized Report Solution

Get a bespoke market intelligence solution

 
We are committed to ensuring the highest level of client satisfaction
Quality Acknowledgement
Quality Acknowledgement

Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you

Unmatched Standards
Unmatched Standards

Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights

Reach Us
Reach Us Whenever You Need Us

With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required

Data Security
Complete Data Security

We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws